Simple Summary Identification of mismatch repair-deficient tumors (MMRd), which occur in
up to 30% of all endometrial cancers (EC), has become unavoidable for therapeutic …

Data on genetic and immunophenotypical characteristics of uterine mesonephric-like
adenocarcinoma (MLA) remain limited. Therefore, we aimed to investigate the …

Background/Aim: The utility of mismatch repair (MMR) immunohistochemistry (IHC) and
microsatellite instability (MSI) testing in uterine mesonephric-like adenocarcinoma (MLA) …

Background/Aim: The expression of L1 cell adhesion molecule (L1CAM) in uterine
mesonephric-like adenocarcinoma (MLA) remains understudied. Our aim was to explore the …

DNA mismatch repair protein deficiency (MMRd) in endometrial carcinoma is associated
with the risk of Lynch syndrome and response to immune checkpoint inhibitors. It is also …

Microsatellite-unstable (MSI) cancers have distinct genetic and clinical features from
microsatellite-stable cancers, but the molecular functional differences between MSI cancers …

Background: This study aimed to analyze the correlation between the 3-year disease-free
survival (DFS) and mismatch repair (MMR) protein levels in patients with type 1 endometrial …

Introduction Precision medicine has revolutionized oncology, providing more personalized
diagnosis, treatment, and monitoring for patients with cancer. In the context of female …

Endometrial cancer is the fourth most common cancer in women and the most common
gynaecological malignancy in the developed world. No new systemic treatments for …

Аннотация Введение. Рак эндометрия (РЭ) занимает лидирующие позиции в структуре
онкогинекологической заболеваемости. Отмечен рост встречаемости данной …